These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 20390305)

  • 1. [Altered pain thresholds during and after opioid withdrawal in patients with chronic low back pain].
    Wang H; Weinsheimer N; Akbar M; Schiltenwolf M
    Schmerz; 2010 Jun; 24(3):257-61. PubMed ID: 20390305
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Does long-term opioid therapy reduce pain sensitivity of patients with chronic low back pain? Evidence from quantitative sensory testing.
    Wang H; Fischer C; Chen G; Weinsheimer N; Gantz S; Schiltenwolf M
    Pain Physician; 2012 Jul; 15(3 Suppl):ES135-43. PubMed ID: 22786452
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Longitudinal observation of changes in pain sensitivity during opioid tapering in patients with chronic low-back pain.
    Wang H; Akbar M; Weinsheimer N; Gantz S; Schiltenwolf M
    Pain Med; 2011 Dec; 12(12):1720-6. PubMed ID: 22082225
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Opioid tolerance and hyperalgesia in chronic pain patients after one month of oral morphine therapy: a preliminary prospective study.
    Chu LF; Clark DJ; Angst MS
    J Pain; 2006 Jan; 7(1):43-8. PubMed ID: 16414554
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transdermal fentanyl versus sustained release oral morphine in strong-opioid naïve patients with chronic low back pain.
    Allan L; Richarz U; Simpson K; Slappendel R
    Spine (Phila Pa 1976); 2005 Nov; 30(22):2484-90. PubMed ID: 16284584
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Case Report: Opioid Therapy for Chronic Low Back Pain].
    Schnabel A; Haaga R; Rittner HL
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2018 Apr; 53(4):306-313. PubMed ID: 29742789
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endogenous Opioid Function and Responses to Morphine: The Moderating Effects of Anger Expressiveness.
    Burns JW; Bruehl S; France CR; Schuster E; Orlowska D; Chont M; Gupta RK; Buvanendran A
    J Pain; 2017 Aug; 18(8):923-932. PubMed ID: 28365372
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized, double-blind, placebo-controlled, cross-over pilot study to assess the effects of long-term opioid drug consumption and subsequent abstinence in chronic noncancer pain patients receiving controlled-release morphine.
    Cowan DT; Wilson-Barnett J; Griffiths P; Vaughan DJ; Gondhia A; Allan LG
    Pain Med; 2005; 6(2):113-21. PubMed ID: 15773875
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence of specific cognitive deficits in patients with chronic low back pain under long-term substitution treatment of opioids.
    Schiltenwolf M; Akbar M; Hug A; Pfüller U; Gantz S; Neubauer E; Flor H; Wang H
    Pain Physician; 2014; 17(1):9-20. PubMed ID: 24452649
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The cognitive impact of chronic low back pain: Positive effect of multidisciplinary pain therapy.
    Schiltenwolf M; Akbar M; Neubauer E; Gantz S; Flor H; Hug A; Wang H
    Scand J Pain; 2017 Oct; 17():273-278. PubMed ID: 28993113
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological and toxicological profile of opioid-treated, chronic low back pain patients entering a mindfulness intervention randomized controlled trial.
    Zgierska A; Wallace ML; Burzinski CA; Cox J; Backonja M
    J Opioid Manag; 2014; 10(5):323-35. PubMed ID: 25350474
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased pain sensitivity in chronic pain subjects on opioid therapy: a cross-sectional study using quantitative sensory testing.
    Zhang Y; Ahmed S; Vo T; St Hilaire K; Houghton M; Cohen AS; Mao J; Chen L
    Pain Med; 2015 May; 16(5):911-22. PubMed ID: 25376890
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in Pain Sensitivity and Pain Modulation During Oral Opioid Treatment: The Impact of Negative Affect.
    Edwards RR; Dolman AJ; Michna E; Katz JN; Nedeljkovic SS; Janfaza D; Isaac Z; Martel MO; Jamison RN; Wasan AD
    Pain Med; 2016 Oct; 17(10):1882-1891. PubMed ID: 26933094
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Do opioids induce hyperalgesia?].
    Zöllner C
    Anaesthesist; 2010 Nov; 59(11):983-6, 988-93. PubMed ID: 20967403
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Opioids in chronic low back pain. A systematic review and meta-analysis of efficacy, tolerability and safety in randomized placebo-controlled studies of at least 4 weeks duration].
    Petzke F; Welsch P; Klose P; Schaefert R; Sommer C; Häuser W
    Schmerz; 2015 Feb; 29(1):60-72. PubMed ID: 25503883
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predicting long-term response to strong opioids in patients with low back pain: findings from a randomized, controlled trial of transdermal fentanyl and morphine.
    Kalso E; Simpson KH; Slappendel R; Dejonckheere J; Richarz U
    BMC Med; 2007 Dec; 5():39. PubMed ID: 18154644
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors affecting acceptability of titrated oxymorphone extended release in chronic low back pain - an individual patient analysis.
    Peniston JH; Xiang Q; Gould EM
    Curr Med Res Opin; 2010 Aug; 26(8):1861-71. PubMed ID: 20521870
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute opioid withdrawal precipitated by ingestion of crushed embeda (morphine extended release with sequestered naltrexone): case report and the focused review of the literature.
    Ruan X; Chen T; Gudin J; Couch JP; Chiravuri S
    J Opioid Manag; 2010; 6(4):300-3. PubMed ID: 20862910
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative sensory tests fairly reflect immediate effects of oxycodone in chronic low-back pain.
    Schliessbach J; Siegenthaler A; Bütikofer L; Vuilleumier P; Jüni P; Arendt-Nielsen L; Curatolo M
    Scand J Pain; 2017 Oct; 17():107-115. PubMed ID: 28850362
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomized, open-label study of once-a-day AVINZA (morphine sulfate extended-release capsules) versus twice-a-day OxyContin (oxycodone hydrochloride controlled-release tablets) for chronic low back pain: the extension phase of the ACTION trial.
    Rauck RL; Bookbinder SA; Bunker TR; Alftine CD; Ghalie R; Negro-Vilar A; de Jong E; Gershon S
    J Opioid Manag; 2006; 2(6):325-8, 331-3. PubMed ID: 17326594
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.